Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis C
ADR ID BADD_A02025
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.09      Hepatic viral infections
09.01.09.005      Hepatitis C
11      Infections and infestations
11.05      Viral infectious disorders
11.05.28      Hepatitis virus infections
11.05.28.004      Hepatitis C
Description INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. [MeSH]
MedDRA Code 10019744
MeSH ID D006526
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute or unspecified hepatitis C with hepatic coma | Acute or unspecified hepatitis C without mention of hepatic coma | Biphasic hepatitis | Hepatitis C | Viral hepatitis C | HCV coinfection | Hepatitis C aggravated | Hepatitis C recurrent | Hepatitis C relapse | Parenterally-Transmitted Non-A, Non-B Hepatitis | Parenterally Transmitted Non A, Non B Hepatitis | PT-NANBH | Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00176Atazanavir--
BADD_D00312Bupropion--
BADD_D00586Darunavir--
BADD_D00595Deferiprone--
BADD_D00704Dolutegravir sodium--
BADD_D00857Etravirine--
BADD_D00858Everolimus--
BADD_D00978Fulvestrant--
BADD_D01160Insulin aspart--
BADD_D01242Lamivudine--
BADD_D01508Mycophenolic acid--
BADD_D01527Naltrexone--
BADD_D01858Propagermanium--
BADD_D01906Raltegravir potassium--
BADD_D01940Rilpivirine--
BADD_D02053Sofosbuvir--
BADD_D02383Zidovudine--
The 1th Page    1    Total 1 Pages